Trial
NCT01836289
High-dose Cyclophosphamide for Severe Refractory Crohn Disease
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Crohn's Disease
Intervention
High-dose Cyclophosphamide
Why stopped
Too difficult to recruit given new Crohn's medications approved
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-13